Methods and compositions for inhibiting CD32b expressing cells

Details for Australian Patent Application No. 2008260498 (hide)

Owner Moore, G. Igor, V. Chu, S. Karki, S. Xencor, Inc. Lazar, G. Desjarlais, J.

Inventors Chu, Seung Yup; Karki, Sher Bahadur; Vostiar, Igor; Lazar, Gregory Alan; Desjarlais, John R.; Moore, Gregory

Agent Davies Collison Cave

Pub. Number AU-A-2008260498

PCT Pub. Number WO2008/150494

Priority 61/032,059 27.02.08 US; 61/046,397 18.04.08 US; 61/012,035 06.12.07 US; 60/990,509 27.11.07 US; 61/043,585 09.04.08 US; 60/976,279 28.09.07 US; 60/940,776 30.05.07 US; 60/970,413 06.09.07 US; 61/013,775 14.12.07 US; 60/953,174 31.07.07 US; 61/019,395 07.01.08 US

Filing date 30 May 2008

Wipo publication date 11 December 2008

International Classifications

C07K 16/28 (2006.01) Immunoglobulins, e.g. monoclonal or polyclonal antibodies

Event Publications

7 January 2010 PCT application entered the National Phase

  PCT publication WO2008/150494 Priority application(s): WO2008/150494

4 February 2010 Assignment before Grant

  Moore, Gregory; Karki, Sher; Chu, Seung; Vostiar, Igor; Lazar, Gregory; Xencor, Inc.; Desjarlais, John The application has been assigned to Xencor, Inc.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2008260510-Pulsatile dosing of gossypol for treatment of disease

2008260496-Tricyclic inhibitors of fatty acid amide hydrolase